In 2023, China's share of top-cited orthopedic and sports medicine publications stood at an estimated value lower than 9.03. From 2024 onwards, projections indicate a steady yearly increase in China's share, growing from 9.03% in 2024 to 10.98% by 2028. Year-on-year variations highlight consistent growth, with an average annual increase (CAGR) over the five-year period suggesting a robust trajectory in the influence of Chinese research in this domain.

Future trends to watch include:

Continued investment in research and development which could accelerate citation growth.
Potential policy changes affecting academic collaborations or funding within China.
Technological advancements in orthopedics and sports medicine that may influence global citation dynamics.